We are live on ! Find out more
ARDS

Aridis Pharmaceuticals Inc. Common Stock
ARDS

Delisted

ARDS was delisted on the 18th of July, 2023.

Back to rankings

1 hedge funds and large institutions have $1.44K invested in Aridis Pharmaceuticals Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 18 → 1 (-17)

100% less capital invested

Capital invested by funds: $392K → $1.44K (-$391K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 17

Holders
1
Holders Change
-17
Holders Change %
-94.44%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$142K
2
RAM
Roumell Asset Management
Maryland
-$98.2K
3
State Street
State Street
Massachusetts
-$44.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$31.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$29.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wealth Architects
California
$1.44K – – –
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
– -$142K -646,000 Closed
RAM
3
Roumell Asset Management
Maryland
– -$98.2K -446,588 Closed
State Street
4
State Street
Massachusetts
– -$44.5K -202,247 Closed
Geode Capital Management
5
Geode Capital Management
Massachusetts
– -$31.5K -143,034 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$29.9K -136,197 Closed
HF
7
HRT Financial
New York
– -$16K -73,723 Closed
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
– -$8K -36,533 Closed
Northern Trust
9
Northern Trust
Illinois
– -$6.18K -28,104 Closed
CWM
10
Cornerstone Wealth Management
Missouri
– -$4.4K -20,000 Closed
TRCT
11
Tower Research Capital (TRC)
New York
– -$3.6K -16,363 Closed
VF
12
Virtu Financial
New York
– -$3K -11,809 Closed
BlackRock
13
BlackRock
New York
– -$1.01K -4,612 Closed
Group One Trading
14
Group One Trading
Illinois
– -$514 -2,337 Closed
Wells Fargo
15
Wells Fargo
California
– -$320 -1,459 Closed
FP
16
Financial Perspectives
Minnesota
– -$55 -250 Closed
IGWM
17
ICA Group Wealth Management
Colorado
– -$55 -250 Closed

ARDS Hedge Fund Activity: Q3 2023 in Review

1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) for Q3 2023, worth a combined $1.44K — down 100% from $392K a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ARDS and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Commonwealth Equity Services, exiting entirely with an estimated $142K sold.

  • 1 institutional investor held Aridis Pharmaceuticals Inc. Common Stock (ARDS) as of Q3 2023, down from 18 in Q2 2023.
  • Funds reported $1.44K of Aridis Pharmaceuticals Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Aridis Pharmaceuticals Inc. Common Stock positions in Q3 2023 and 17 closed out, a net change of -17 holders.
  • The largest Aridis Pharmaceuticals Inc. Common Stock seller in Q3 2023 was Commonwealth Equity Services, an estimated $142K sold.

Based on aggregated 13F filings for Q3 2023.